Analysis and findings included in TBRC reports and presentations are our estimates, opinions and are not intended as statements of fact or investment guidance
Information for GLOW Blend The GLOW blend is a research formulation combining GHK-Cu, TB-500, and BPC 157, each selected for its distinct biochemical role in molecular and tissue-level investigations
Tirzepatide carries a boxed warning for thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Grassroots communities within the company, including one called Addicted to Learning with 800 members, have arisen to encourage further learning about new technologies, including AI and generative AI
Current research developments focus on expanding FOXO4-DRI applications beyond traditional aging studies to include investigation of fibrosis, neurodegeneration, and immune system aging
IV therapy is intended as supportive care, not a replacement for nutrition or medical management
